Etiology, Diagnosis, and Management of Vaginitis

Journal of Midwifery and Women's Health

Volumn 51, Issue 6, 2006, Pages 423-430

  Mashburn, Jane ^a  

^a NONE

Author keywords

bacterial vaginosis; trichomoniasis; vulvovaginal candidiasis

Indexed keywords

BUTOCONAZOLE; CLINDAMYCIN; CLOTRIMAZOLE; FLUCONAZOLE; GYNAZOLE; METRONIDAZOLE; MICONAZOLE; NYSTATIN; PROBIOTIC AGENT; TERCONAZOLE; TINIDAZOLE; TIOCONAZOLE;

ARTICLE; BACTERIUM IDENTIFICATION; BACTEROIDES; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CIGARETTE SMOKING; CONDOM; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG HALF LIFE; FEMALE; FUNGUS CULTURE; GARDNERELLA VAGINALIS; GASTROINTESTINAL DISEASE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTOBACILLUS; LESBIANISM; MEDICAL CARE; MICROSCOPY; MOBILUNCUS; MYCOPLASMA HOMINIS; PATHOGENESIS; PEPTOSTREPTOCOCCUS; PH; PREGNANCY OUTCOME; PREMATURE LABOR; PREVOTELLA; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UREAPLASMA UREALYTICUM; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINAL LAVAGE; VAGINITIS; VULVA PRURITUS;

ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PHYSICAL EXAMINATION; TRICHOMONAS VAGINITIS; VAGINAL DISCHARGE; VAGINITIS; VAGINOSIS, BACTERIAL; WOMEN'S HEALTH;

EID: 33750378324     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2006.07.005     Document Type: Article

References (43)

1. Owen M.K., and Clenney T.L. Management of vaginitis. Am Fam Physician 70 (2004) 2125-2132 2139-40
2. Ferris D.G., Nyirjesy P., Sobel J.D., Soper D., Pavletic A., and Litaker M.S. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 99 (2002) 419-425
3. Landers D.V., Wiesenfeld H.C., and Helene R.P. Predictive values of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 190 (2004) 1004-1010
4. Soper D.E. Taking the guesswork out of diagnosing and managing vaginitis. Contempoary OB/GYN 50 (2005) 32-39
5. Klebanoff M.A., Schwebke J.R., Zhang J., Nansel T.R., Yu K.F., and Andrews W.W. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol 104 (2004) 267-272
6. Beigi R.H., Austin M.N., Meyn L.A., Krohn M.A., and Hilleir S.L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191 (2004) 1124-1129
7. Weir E. Bacterial vaginosis: more questions than answers. Can Med Assoc J 171 (2004) 448-501
8. Priestly C.J., Jones B.M., Dhar J., and Goodwin L. What is normal vaginal flora?. Genitourin Med 73 (1997) 23-28
9. Begum A., Nilufar S., Akther K., Rahman A., Khatoon F., and Rahman M. Prevalence of selected reproductive tract infections among pregnant women attending an urban maternal and childcare unit in Dhaka, Bangladesh. J Health Popul Nutr 21 (2003) 112-116
10. Clinical feature. Bacterial vaginosis and inflammatory vaginitis. Am J Obstet Gynecol 190 (2004) 1503
11. Ness R.B., Hillier S.L., Kip K.E., Soper D.E., Stamm C.A., McGregor J.A., et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 104 (2004) 761-769
12. Bailey J.V., Farquhar C., and Owen C. Bacterial vaginosis in lesbians and bisexual women. Sex Transm Dis 31 (2004) 691-694
13. Fiscella K., and Klebanoff M.A. Are racial differences in vaginal pH explained by vaginal flora?. Am J Obstet Gynecol 191 (2004) 747-750
14. Sanchez S., Garcia P.J., Thomas K.K., Catlin M., and Holmes K.K. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol 191 (2004) 1898-1906
15. Verstraelen H., Verhelst R., Claeys G., Temmerman M., and Vaneechouute M. Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginsosi. Am J Obstet Gynecol 191 (2004) 1130-1132
16. Alfonsi G.A., Shlay J.C., and Parker S. What is the best approach for managing recurrent bacterial vaginosis?. J Fam Prac 53 (2004) 650-652
17. Zhang J., Hatch M., Zhang D., Shulman J., Harville E., and Thomas A.G. Frequency of douching and risk of bacterial vaginosis in African American women. Obstet Gynecol 104 (2004) 756-760
18. Schwebke J.R., Desmond R.A., and Oh M.K. Predictors of bacterial vaginosis in adolescent women who douche. Sex Transm Dis 31 (2004) 433-436
19. Bornstein J., Lakovsky Y., Lavi I., Bar-Am A., and Abramovici H. The classis approach to diagnosis of vulvovaginitis: a critical analysis. Infect Dis Obstet Gynecol (2001) 105-111
20. Schaff V.M., Perez-Stable E., and Borchart K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 150 (1990) 1929-1933
21. Amsel A., Totten P.A., Spiegel C.A., Eschenbach D., and Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983) 14-22
22. Brown H.L., Fuller D.D., Jasper L.T., Davis T.E., and Wright J.D. Clinical evaluation of Affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol (2004) 12-17
23. Medcompare Web site. Available at: http://www.medcompare.com/prodalerts [Accessed August 4, 2006].
24. Gutman R.E., Peipert J.F., Weitzen S., and Blume J. Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet Gynecol 105 (2005) 551-556
25. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 55 RR-11 (2006) 1-95. http://www.cdc.gov Available from: www.cdc.gov
26. Kane K.Y., and Pierce R. What are the most effective treatments for bacterial vaginosis in nonpregnant women?. J Fam Pract 50 (2001) 399-400
27. Kloumans E.H., Markowitz L.E., and Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis 35 suppl 2 (2002) 5152-5172
28. Burtin P., Taddio A., Einarson T.R., and Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 172 2 Pt 1 (1995) 525-529
29. Sobel J.D., Ferris S., Schwebke J., Nyirjesy P., Wiesenfeld H.C., Peipert J., Soper D., et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 194 5 (2006) 1283-1289 May
30. French L., Horton J., and Matousek M. Abnormal vaginal discharge: what does and does not work in the underlying causes. J Fam Pract 53 (2004) 890-894
31. Baylson F.A., Nyirjesy P., and Weitz M.V. Treatment of recurrent bacterial vaginosis with tinidazole. Obstet Gynecol 104 (2004) 931-932
32. Sobel J.D. What's new in bacterial vaginosis and trichomonas?. Infect Dis Clin N Am (2005) 387-406
33. Swygard H., Miller W.C., Kaydos-Daniels S.C., Cohen M.S., Leone P.A., Hobbs M.M., et al. Targeted screening for Trichomonis vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis 31 (2004) 659-664
34. Riggs M.A., and Klebanoff M.A. Treatment of vaginal infections to prevent preterm birth: a meta-analysis. Clin Obstet Gynecol 47 (2004) 796-807
35. Okun N., Gronau K.A., and Hannah M.E. Antibiotics for bacterial vaginosis or trichomonas vaginalis in pregnancy: a systemic review. Obstet Gynecol 105 (2005) 857-868
36. Klebanoff M.A., Carely J.C., Hauth J.C., Hillier S.L., Nugent R.P., Thom E.A., et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic trichomonas vaginalis infection. N Engl J Med 345 (2001) 487-493
37. Beigi R.H., Meyn L.A., Moore D.M., Krohn M.A., and Hillier S.L. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol 104 (2004) 926-930
38. Eschenbach D.A. Chronic vulvovaginal candidiasis. N Engl J Med 351 (2004) 851-852
39. Neafsey P.J., and Donat D. Bugs, drugs, and yogurt. Home Healthc Nurse 23 (2005) 13-15
40. Pirotta M., Gunn J., Chondros P., Grover S., O'Malley P., Hurley S., et al. Effect of lactobacillus in precenting post-antiobiotic vulvovaginal candidiasis: a randomized controlled trial. BMJ 329 (2004) 548-558
41. Hilton E, Isenberg HD, Alperstein P, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med;116:353-7.
42. Jeavons H.S. Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus. J Obstet Gynecol Neonatal Nurs 32 (2003) 287-296
43. Nishijima K., Shukunami K., and Kotsuji F. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol 104 5 Pt 1 (2004) 1106-1107